Related Experiment Video
Updated: Mar 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in
Karin H Humphries1,2, G B John Mancini1
1University of British Columbia, Division of Cardiology, Vancouver, Canada.
No abstract available in PubMed .
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Pharmacogenomics: Identification of New Drug Targets
Lipids: Dietary Sources and Requirements